ClinicalTrials.gg
Status unknownNCT04396483Updated Nov 27, 2023

Dysfunctional Uterine Bleeding After Tubal Sterilization

An interventional study of Pomeroy's tubal sterilization and Salpingectomy in Contraception and Dysfunctional Uterine Bleeding, sponsored by Tanta University. Status unknown at 2 sites in Egypt. Open to female participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2023-11-27.

Sponsored by Tanta University · Not applicable, Interventional, and Basic science

The sponsor has not verified this record recently (last verified Nov 2023), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
220
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
Female
01

Study summary

In this study, the investigators will compare the frequency and amount of bleeding after tubal sterilization and salpingectomy

Read the detailed description

Dysfunctional uterine bleeding is common after tubal sterilization.

The investigators will compare the frequency and amount of bleeding after two techniques eithe tubal sterilization by pomeroy's method during cesarean section or complete salpingectomy

02

Conditions studied

  • Contraception
  • Dysfunctional Uterine Bleeding

Browse trials for

Keywords

  • Dysfunctional uterine bleeding
  • Tubal sterilization
  • Salpingectomy
  • Cesarean section
03

In context

Metrorrhagia

102 studies on the registry are indexed under Metrorrhagia; 26 are open to participants now.

This study's planned enrollment of 220 is above the median of 109 across 78 interventional studies indexed under Metrorrhagia.

Browse Metrorrhagia studies →

Lead sponsor

Tanta University is the lead sponsor of 991 studies on the registry; 316 are open to participants now.

Of its 16 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 20-40
  • Patient completed her family
  • Patient on cesarean delivery

Exclusion criteria

Exclusion Criteria:

  • Tubal sterilization by other methods
  • Salpingectomy by laparoscopy
  • Patient wishing fertility
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
220 participants (estimated)

Study arms

  • Experimental
    Tubal sterilization "Pomeroy's method"

    Procedure: Pomeroy's tubal sterilization

  • Active comparator
    Salpingectomy

    Procedure: Salpingectomy

Interventions

  • ProcedurePomeroy's tubal sterilization

    Both Fallopian tubes will be grasped by allis forceps and a kokher forceps will be applied below the allis forceps then excision of tubal part above kokher and transfixation of both ends away from each other during cesarean section

  • ProcedureSalpingectomy

    Both fallopian tubes will be completely removed during cesarean section

06

What researchers measure

Primary outcomes

  1. Frequency of Dysfunctional bleeding

    percentage of cases suffering of dysfunctional bleeding

    Time frame: 1 year after cesarean section

  2. Amount of bleeding

    number of sanitary pads during bleeding

    Time frame: 1 year after cesarean section

07

Study locations

2 of 2 sites recruiting
  • Adel Elgergawy
    Tanta, Gharbia Governorate 31111, Egypt
    Recruiting
  • Ayman Shehata Dawood
    Tanta, Gharbia Governorate 31111, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — When valid request is present

Supporting information: Study protocol

Time frame: 6 months

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 27, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04396483
Lead sponsor
Tanta University
Responsible party
Ayman S Dawood, MD (Principal investigator, Tanta University) — Principal investigator
First posted
May 20, 2020
Start date
Jun 1, 2021
Primary completion
Mar 31, 2024 (estimated)
Completion
Mar 31, 2024 (estimated)
Last update
Nov 27, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion